Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Todd Korthuis

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Qualitative Health Research|June 3, 2021
Experimental (Re)structuring: The Clinical Trial as Turning Point Among Medical Research ParticipantsKaitlyn Jaffe, P Todd Korthuis, Lindsey Richardson
Annual Review of Medicine|October 12, 2023
Novel Therapeutic and Program-Based Approaches to Opioid Use DisordersPatricia Liu, P Todd Korthuis, Bradley M Buchheit
Current HIV/AIDS Reports|January 27, 2019
Medications for Treatment of Opioid Use Disorder among Persons Living with HIVLaura Fanucchi, Sandra A Springer, P Todd Korthuis
Annual Review of Public Health|December 23, 2017
Treatment and Prevention of Opioid Use Disorder: Challenges and OpportunitiesDennis McCarty, Kelsey C Priest, P Todd Korthuis
Annual Review of Psychology|August 2, 2024
Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big MoneyKeith Humphreys, P Todd Korthuis, Daniel Stjepanović, et al.
Journal of Addiction Medicine|November 12, 2020
Participants' Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical ResearchGeoff Bardwell, Kaitlyn Jaffe, P Todd Korthuis, et al.
The American Journal of Managed Care|July 19, 2011
Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilizationWilliam C Bryson, John McConnell, P Todd Korthuis, et al.
Lancet (London, England)|October 31, 2006
Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analysesRoger Chou, Rongwei Fu, Laurie Hoyt Huffman, et al.
Journal of General Internal Medicine|December 14, 2016
"It's been an Experience, a Life Learning Experience": A Qualitative Study of Hospitalized Patients with Substance Use DisordersChristine M Velez, Christina Nicolaidis, P Todd Korthuis, et al.
Journal of Substance Abuse Treatment|September 25, 2020
Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysisCaroline King, Christina Nicolaidis, P Todd Korthuis, et al.
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Qualitative Health Research|June 3, 2021
Experimental (Re)structuring: The Clinical Trial as Turning Point Among Medical Research ParticipantsKaitlyn Jaffe, P Todd Korthuis, Lindsey Richardson
Annual Review of Medicine|October 12, 2023
Novel Therapeutic and Program-Based Approaches to Opioid Use DisordersPatricia Liu, P Todd Korthuis, Bradley M Buchheit
Current HIV/AIDS Reports|January 27, 2019
Medications for Treatment of Opioid Use Disorder among Persons Living with HIVLaura Fanucchi, Sandra A Springer, P Todd Korthuis
Annual Review of Public Health|December 23, 2017
Treatment and Prevention of Opioid Use Disorder: Challenges and OpportunitiesDennis McCarty, Kelsey C Priest, P Todd Korthuis
Annual Review of Psychology|August 2, 2024
Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big MoneyKeith Humphreys, P Todd Korthuis, Daniel Stjepanović, et al.
Journal of Addiction Medicine|November 12, 2020
Participants' Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical ResearchGeoff Bardwell, Kaitlyn Jaffe, P Todd Korthuis, et al.
The American Journal of Managed Care|July 19, 2011
Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilizationWilliam C Bryson, John McConnell, P Todd Korthuis, et al.
Lancet (London, England)|October 31, 2006
Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analysesRoger Chou, Rongwei Fu, Laurie Hoyt Huffman, et al.
Journal of General Internal Medicine|December 14, 2016
"It's been an Experience, a Life Learning Experience": A Qualitative Study of Hospitalized Patients with Substance Use DisordersChristine M Velez, Christina Nicolaidis, P Todd Korthuis, et al.
Journal of Substance Abuse Treatment|September 25, 2020
Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysisCaroline King, Christina Nicolaidis, P Todd Korthuis, et al.
Pageof 22